CD19 and leukemia: The cytocidal action of imatinib-encapsulated CD19-liposomes (imatinib-CD19-liposomes) on Ph(+) ALL cell lines and primary leukemia cells from subjects with Ph(+) ALL was much greater than that of imatinib with or without control liposomes [93].